Erik Greb joined the staff of Neurology Reviews in January 2012. Since then, he has attended scientific conferences, conducted video interviews, and written about clinical research in multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, stroke, and other neurologic disorders. In addition to news articles, Erik has written investigative stories about multiple sclerosis, headache, and epilepsy. He previously wrote about pharmaceutical manufacturing, drug formulation and delivery, quality assurance, and regulation for Pharmaceutical Technology.
News
Influenza vaccination modestly reduces risk of hospitalizations in patients with COPD
Older patients with COPD need more effective influenza vaccines and other preventive strategies.
News
Investigators use ARMSS score to predict future MS-related disability
STOCKHOLM – The score is the basis for a measurement that is stable over time.
News
Continuation of natalizumab treatment reduces risk of MS relapses during pregnancy
STOCKHOLM – Natalizumab treatment after the first trimester may not be associated with significant fetal risks.
News
Many institutions exceed recommended radiation doses during lung cancer screening
Allowing any radiologist, rather than a lead radiologist, to establish CT protocols is associated with high likelihood of exceeding ACR dose...
News
Ofatumumab has superior efficacy in relapsing-remitting MS, compared with teriflunomide
STOCKHOLM – The monoclonal antibody reduced annualized relapse rate and the risk of confirmed disability worsening,...
News
Average daily step count reflects disability in MS
STOCKHOLM – Step count can be monitored remotely and correlates with measures of walking performance, cognitive...
News
Ponesimod reduces annualized relapse rate, compared with teriflunomide
STOCKHOLM – The investigational MS treatment is superior to the approved drug on measures of fatigue and active...
News
Continuous treatment reduces risk of confirmed disability progression in MS
STOCKHOLM – The risk of confirmed disability progression appears to decrease with increasing length of continuous...
News
How does diet affect the risk of IBD?
CHICAGO – Consumption of various foods increases the risk of incident IBD and may provoke associated symptoms.
News
How does diet affect the risk of IBD?
CHICAGO – Consumption of various foods increases the risk of incident IBD and may provoke associated symptoms.
News
Diagnosis and management of gastroparesis and functional dyspepsia pose challenges
CHICAGO – Although these disorders share symptoms in common, patients respond differently to therapy.
News
Is serum serotonin level associated with risk of seizure-related breathing dysfunction?
A prospective study of patients with intractable epilepsy may indicate physiologic changes that protect against phenomena that lead to SUDEP.
News
Diagnosis and management of gastroparesis and functional dyspepsia pose challenges
CHICAGO – Although these disorders share symptoms in common, patients respond differently to therapy.
News
What is the best treatment for mast cell activation syndrome?
CHICAGO – Medicines that target mast cells are effective, and treatment also should include dietary modifications...
News
Prices, out-of-pocket costs for MS drugs rose despite competition
Rather than decreasing prices, the introduction of new self-administered therapies after 2009 may have contributed to increased prices.